XETRA - Delayed Quote EUR

Heidelberg Pharma AG (HPHA.DE)

3.2500

-0.0200

(-0.61%)

As of 12:03:25 PM GMT+2. Market Open.

RedHill Biopharma Secures Allowance of Key Chinese Patent Application for Proprietary COVID-19 Treatment, RHB-107

RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that the China National Intellectual Property Administration ("CNIPA") has formally allowed a critical use of composition-of-matter patent for RedHill's proprietary investigational compound RHB-107 (upamostat), a potential oral treatment for COVID-19 (patent application No. 202311591091.6).

PR Newswire 23 days ago

HPHA.F

RDHL
Heidelberg Pharma First Quarter 2025 Earnings: €0.13 loss per share (vs €0.10 loss in 1Q 2024)

Heidelberg Pharma ( ETR:HPHA ) First Quarter 2025 Results Key Financial Results Revenue: €2.87m (up 127% from 1Q 2024...

Simply Wall St. 25 days ago

HPHA.DE
-0.61%
European Penny Stocks To Watch In April 2025

As the European markets rebound, with major stock indexes rising and the STOXX Europe 600 Index climbing 3.93% over a recent week, investor sentiment has been buoyed by the European Central Bank's rate cuts and delayed tariff impositions by President Trump. In this context, penny stocks—though an older term—remain relevant as they often represent smaller or newer companies that can offer growth opportunities at lower price points. By focusing on those with strong balance sheets and solid...

Simply Wall St. 28 days ago

ANORA.HE

HPHA.DE
-0.61%

ININ.OL
European Penny Stocks To Watch In March 2025

As European markets experience a mixed performance, with the pan-European STOXX Europe 600 Index ending slightly higher amid hopes for increased government spending, investors are keeping a close eye on developments. In such times of economic uncertainty and evolving trade dynamics, penny stocks—often smaller or newer companies—continue to attract interest due to their potential for growth and affordability. Though the term "penny stock" might seem outdated, these investments can still offer...

Simply Wall St. last month

ININ.OL

PRBCF

HPHA.DE
-0.61%
Heidelberg Pharma Full Year 2024 Earnings: Beats Expectations

Heidelberg Pharma ( ETR:HPHA ) Full Year 2024 Results Key Financial Results Revenue: €12.0m (up 21% from FY 2023). Net...

Simply Wall St. last month

HPHA.DE
-0.61%
3 Promising Penny Stocks With Market Caps Under US$800M

Amidst a backdrop of geopolitical tensions and consumer spending concerns, major U.S. stock indexes have experienced fluctuations, closing lower after an initial rise earlier in the week. In such volatile times, investors often seek opportunities in less conventional areas of the market. Penny stocks, despite their somewhat antiquated name, continue to attract attention for their potential value and growth prospects. These smaller or newer companies can offer affordability coupled with...

Simply Wall St. 2 months ago

HPHA.DE
-0.61%

KWHAF
Investors in Heidelberg Pharma (ETR:HPHA) have unfortunately lost 40% over the last three years

As an investor its worth striving to ensure your overall portfolio beats the market average. But if you try your hand...

Simply Wall St. 3 months ago

HPHA.DE
-0.61%
Spotlight On 3 Penny Stocks With Market Caps Over US$100M

As global markets navigate a mixed landscape of rising treasury yields, fluctuating consumer confidence, and varied economic data across regions, investors are seeking opportunities that align with these dynamic conditions. Penny stocks, often smaller or newer companies, remain an intriguing option for those willing to explore beyond established market giants. Despite the term's outdated connotations, these stocks can offer significant potential when underpinned by strong financials and...

Simply Wall St. 4 months ago

HPHA.DE
-0.61%

9909.HK
Here's Why We're Watching Heidelberg Pharma's (ETR:HPHA) Cash Burn Situation

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

Simply Wall St. 4 months ago

HPHA.DE
-0.61%
November 2024's Promising Penny Stocks To Consider

Global markets have recently shown resilience, with U.S. indexes approaching record highs and broad-based gains despite geopolitical tensions and policy uncertainties. In the context of these market dynamics, penny stocks—often representing smaller or newer companies—remain an intriguing area for investors seeking potential value. While the term "penny stock" may seem outdated, it still signifies opportunities in companies that can offer significant returns if they possess strong financial...

Simply Wall St. 5 months ago

VVCHF

HPHA.DE
-0.61%
Heidelberg Pharma Third Quarter 2024 Earnings: €0.13 loss per share (vs €0.002 profit in 3Q 2023)

Heidelberg Pharma ( ETR:HPHA ) Third Quarter 2024 Results Key Financial Results Revenue: €3.56m (up 59% from 3Q 2023...

Simply Wall St. 7 months ago

HPHA.DE
-0.61%
With 46% ownership, Heidelberg Pharma AG (ETR:HPHA) insiders have a lot at stake

Key Insights Insiders appear to have a vested interest in Heidelberg Pharma's growth, as seen by their sizeable...

Simply Wall St. 7 months ago

HPHA.DE
-0.61%
Shareholders in Heidelberg Pharma (ETR:HPHA) are in the red if they invested three years ago

If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly. But...

Simply Wall St. 8 months ago

HPHA.DE
-0.61%
Is Heidelberg Pharma (ETR:HPHA) In A Good Position To Invest In Growth?

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

Simply Wall St. 10 months ago

HPHA.DE
-0.61%

Performance Overview

Return	HPHA.DE	DAX P (^GDAXI)
YTD	+33.20%	+19.98%
1-Year	+9.43%	+27.87%
3-Year	-33.94%	+70.84%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Heidelberg Pharma AG (HPHA.DE)

RedHill Biopharma Secures Allowance of Key Chinese Patent Application for Proprietary COVID-19 Treatment, RHB-107

Heidelberg Pharma First Quarter 2025 Earnings: €0.13 loss per share (vs €0.10 loss in 1Q 2024)

European Penny Stocks To Watch In April 2025

European Penny Stocks To Watch In March 2025

Heidelberg Pharma Full Year 2024 Earnings: Beats Expectations

3 Promising Penny Stocks With Market Caps Under US$800M

Investors in Heidelberg Pharma (ETR:HPHA) have unfortunately lost 40% over the last three years

Spotlight On 3 Penny Stocks With Market Caps Over US$100M

Here's Why We're Watching Heidelberg Pharma's (ETR:HPHA) Cash Burn Situation

November 2024's Promising Penny Stocks To Consider

Heidelberg Pharma Third Quarter 2024 Earnings: €0.13 loss per share (vs €0.002 profit in 3Q 2023)

With 46% ownership, Heidelberg Pharma AG (ETR:HPHA) insiders have a lot at stake

Shareholders in Heidelberg Pharma (ETR:HPHA) are in the red if they invested three years ago

Is Heidelberg Pharma (ETR:HPHA) In A Good Position To Invest In Growth?

Performance Overview